Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
PHILADELPHIA, Sept. 05, 2025 (GLOBE NEWSWIRE) -- The law firm of Kaskela Law LLC announces that it is continuing to investigate the proposed buyout of Verint (NASDAQ: VRNT) shareholders to determine...
-
PHILADELPHIA, Sept. 05, 2025 (GLOBE NEWSWIRE) -- The law firm of Kaskela Law LLC announces that it is continuing to investigate the proposed buyout of Soho House & Co Inc. (NYSE: SHCO) (“Soho...
-
PHILADELPHIA, Sept. 05, 2025 (GLOBE NEWSWIRE) -- The law firm of Kaskela Law LLC announces that it is continuing to investigate the proposed buyout of WideOpenWest, Inc. (NYSE: WOW) shareholders to...
-
PHILADELPHIA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC is investigating the fairness of the proposed buyout of WideOpenWest, Inc. (NYSE: WOW) shareholders at $5.20 per share to determine...
-
PHILADELPHIA, July 14, 2025 (GLOBE NEWSWIRE) -- Investor protection firm Kaskela Law LLC announces that it has launched an investigation into the fairness of the recently announced proposed buyout...
-
PHILADELPHIA, July 14, 2025 (GLOBE NEWSWIRE) -- Investor protection firm Kaskela Law LLC announces that it has launched an investigation into the fairness of the recently announced buyout of TaskUs,...
-
PHILADELPHIA, July 09, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating the fairness of the recently announced proposed buyout of Guess? Inc. (NYSE: GES) shareholders to...
-
PHILADELPHIA, July 09, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating the fairness of the recently announced proposed buyout of NV5 Global, Inc. (Nasdaq: NVEE) (“NV5”)...
-
PHILADELPHIA, June 26, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) (“Agios”) on behalf of the company’s long-term...
-
PHILADELPHIA, June 26, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Trevi Therapeutics, Inc. (NASDAQ: TRVI) (“Trevi”) on behalf of the company’s long-term investors. ...